Testosterone therapy improves bone density in men with hypogonadism, but large trials of long duration are needed to assess the effects of treatment on the incidence of fractures.
New research findings are summarized in a short video.
https://www.nejm.org/doi/pdf/10.1056/NEJMoa2308836 Background Testosterone treatment in men with hypogonadism improves bone density and quality, but trials with a sufficiently large sample and a sufficiently long duration to determine the effect of testosterone on the incidence of fractures...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.